A randomized phase II clinical trial of stereotactic body radiation therapy (SBRT) and systemic pembrolizumab with or without intratumoral avelumab/ipilimumab plus CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells in solid tumors
Titel:
A randomized phase II clinical trial of stereotactic body radiation therapy (SBRT) and systemic pembrolizumab with or without intratumoral avelumab/ipilimumab plus CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells in solid tumors
Auteur:
Vounckx, Manon Tijtgat, Jens Stevens, Latoya Dirven, Iris Ilsen, Bart Vandenbroucke, Frederik Raeymaeckers, Steven Vekens, Karolien Forsyth, Ramses Geeraerts, Xenia Van Riet, Ivan Schwarze, Julia Katharina Tuyaerts, Sandra Decoster, Lore De Ridder, Mark Dufait, Ines Neyns, Bart